Detalhe da pesquisa
1.
Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.
PLoS Med
; 11(11): e1001760, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25423041
2.
DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
PLoS One
; 12(5): e0178054, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28542441
3.
Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa.
Trans R Soc Trop Med Hyg
; 109(7): 425-32, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25979526
4.
Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa.
Open Forum Infect Dis
; 2(1): ofv014, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26034764
5.
Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
PLoS One
; 5(11): e13901, 2010 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21085569